Connect with us

Covid

Recovered From Covid? Get screened every 6 months to avoid heart diseases

Published

on

Recovered From Covid? Get screened every 6 months to avoid heart diseases

Patients who have recovered from Covid may experience symptoms after a long time. Experts recommend getting checked every six months to avoid health complications.

Despite the fact that scientists and doctors continue to learn more about the novel coronavirus, many elements of the virus and the disease it causes are still unknown. While the majority of COVID-19 infections are minor and short-lived, some people are left with symptoms months after clinically testing negative for the virus. This condition is referred to as ‘long Covid’ and it can have a debilitating effect on the lives of people who have recovered from the deadly disease.

Dr TS Kler, Chairman, Fortis Heart & Vascular Institute, Gurugram & Fortis Hospital, Vasant Kunj, told IANS that almost 75-80% of COVID patients don’t need to be admitted to the hospital and can heal at home with teleconsultation, although COVID-19 infections can have long-term consequences. COVID symtoms have been known to last for several months in certain cases.”

Cardiovascular Diseases More Common In Covid Patients. Further explaining the long-term effects of Covid, Dr Kler wrote “aside from lung damage, the virus can also cause immediate myocardial injury and long-term cardiovascular disease.”

According to a study published in the European Heart Journal, Covid-19 patients who experience cardiac arrest have a higher risk of dying than those who do not have the virus, and women are at a higher risk of mortality for the same reason. Within the myocardial tissue, the virus may directly penetrate the ACE2 receptor cells and induce viral damage. COVID can cause myocarditis, which is an inflammation of the heart muscles that can lead to heart failure over time if not treated.

Patients With Pre-Existing Heart Problems Should Be Extra Cautious

People who have a history of heart disease should be extra cautious. During the recuperation phase, a large proportion of patients have experienced cardiac arrest, which often results in death. Experts believe that even when the COVID virus fades, the immune response remains hyperactive, which frequently attacks other organs. Nearly 80% of these patients experienced cardiac arrests within 2-3 weeks of testing positive for COVID.

Get Screened Every Six Months Post Covid Recovery

Several cases of cardiac arrest following COVID recovery have highlighted the significance of regular heart health monitoring. According to doctors, in high-risk patients with pre-existing diseases including diabetes and hypertension, cardiac tests such as ECG, X-Ray Chest, and lipid profile should be done every six months to determine whether the heart has been damaged.

Aside from regular monitoring, post-COVID patients must follow a healthy diet that includes all vital nutrients and excludes spicy, oily, canned, artificial sweeteners, and processed flavours, as well as junk food. Physical activity, as well as a reduction in drinking and smoking, must be prioritised. Even the tiniest of symptoms should be considered, and an expert doctor should be consulted as soon as possible.

Covid

Covaxin protects recipients from severe Covid-19: Researchers

Published

on

By

Covaxin protects recipients from severe Covid-19: Researchers

According to the researchers, India’s Covaxin activates key memory components of the human immune system that can continue to protect recipients from severe Covid-19 even after the vaccine-generated anti-viral antibodies have waned.

“We see amazingly robust immune memory responses very similar to those caused by the natural infection,” said Nimesh Gupta, a scientist at the National Institute of Immunology (NII), New Delhi, who led the study.

“These memory responses will outlast and confer protection even the concentrations of the initial antibodies deplete over months,” Gupta said.

Continue Reading

Covid

Covid-19 in India: 8,488 new Covid cases in last 24 hours, lowest in 538 days

Published

on

By

On Monday, India reported 8,488 new cases over the previous 24 hours, 19.1% lower than Sunday’s statistics. This was the lowest in 538 days.

With this, country’s cumulative caseload to 3,45,18,901. The number of active cases now stands at 1,18,443 — the lowest in 534 days.

As per the Health Ministry data, as many as 12,510 recoveries were recorded on Monday over the previous 24 hours while the number of deaths stood at 249, taking the total toll to 4,65,911.

The top five states that registered the maximum cases were Kerala with 5,080 cases, followed by Tamil Nadu with 756 cases, West Bengal with 727 cases, Maharashtra with 298 cases, and Karnataka with 247 cases. As much as 83.75% of the new cases were reported from these five states.

Continue Reading

Covid

Covaxin 77.8% effective against Covid-19

Published

on

By

Covaxin 77.8% effective against Covid-19

Medical journal Lancet has now stated that the made-in-India vaccine is 77.8 per cent effective against symptomatic Covid, as demonstrated by the phase 3 data. This came out after the World Health Organisation (WHO) approved Bharat Biotech’s Covaxin for emergency use.

The efficacy data demonstrated 70.8 per cent protection against all variants of the SARS-CoV-2 virus.

As per the phase 3 data, Covaxin was found to be 65.2 per cent effective against the Delta variant, 93.4 per cent effective against severe symptomatic Covid and 63.6 per cent effective against asymptomatic Covid.

Dr. Krishna Ella, CMD of Bharat Biotech said, “The peer-review of Covaxin phase III clinical trial data in The Lancet, an authoritative voice in global medicine, validates our commitment to data transparency and meeting the stringent peer-review standards of world-leading medical journals. This accomplishment reflects the undeterred commitment by my team members at Bharat Biotech, our public partners, Indian Council of Medical Research, National Institute of Virology, and the trust imposed by our trial participants who made this happen.”

Continue Reading

Trending